Revolution Medicines CEO Goldsmith sells $1.8 million in stock By Investing.com - Stock Watch Index

Revolution Medicines CEO Goldsmith sells $1.8 million in stock By Investing.com

November 12, 2025

Revolution Medicines CEO Goldsmith sells $1.8 million in stock

Search

RECENT PRESS RELEASES

Collaboration With Samsung and SK Hynix Might Change The Case For Investing In ASML Holdin

SWI Editorial Staff2025-11-13T03:12:44-08:00November 13, 2025|

Private Markets for Main Street: What Financial Advisers’ Clients Need to Know

SWI Editorial Staff2025-11-13T03:12:24-08:00November 13, 2025|

Chaos Industries raises $510 million in series D funding round By Investing.com

SWI Editorial Staff2025-11-13T03:11:58-08:00November 13, 2025|

Bilibili quarterly earnings per share exceed consensus estimates By Investing.com

SWI Editorial Staff2025-11-13T03:11:42-08:00November 13, 2025|

Earnings call transcript: Poste Italiane Q3 2025 sees record revenues By Investing.com

SWI Editorial Staff2025-11-13T03:11:25-08:00November 13, 2025|

Top US Business Services Stocks to Buy, According to Bernstein By Investing.com

SWI Editorial Staff2025-11-13T03:11:08-08:00November 13, 2025|

Related Post